Skip to content

The Impact of ERAS Program in Cardiac Surgery on Patient Prognosis

The Impact of ERAS Program in Cardiac Surgery on Patient Prognosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04642274
Enrollment
400
Registered
2020-11-24
Start date
2021-07-01
Completion date
2023-11-30
Last updated
2025-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ERAS

Keywords

ERAS, Cardiac surgery

Brief summary

The aim of the study is to develop, verify and optimize the ERAS protocol for cardiac surgery.

Detailed description

The aim of the study is to develop, verify and optimize the ERAS protocol for cardiac surgery, thereby improving the overall prognosis of cardiac surgery patients, reducing the incidence of complications, and shortening the length of hospital stay.

Interventions

OTHERPreoperative Strategies

Patient Education Preoperative Oral Carbohydrate Loading Nutritional Optimization Glycemic Control Anemia Correction Preoperative Hair Removal

OTHERIntraoperative Strategies

Anesthetic Technique (Multimodal Analgesia) Antibiotics Glycemic Control Blood Transfusion Blood Conservation Optimization of Hemodynamics Protective Lung Ventilation Strategy Optimization of Anesthetic Depth Optimization of CPB Management

OTHERPostoperative Strategies

Postoperative Analgesia Temperature Management Renal Protection Glycemic Control Early Extubation Early Oral Intake Maintain Drain Patency and Early Removal Early Ambulation Thromboprophylaxis

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 80 years. * Undergoing elective surgery. * Scheduled for cardiac valve surgery with cardiopulmonary bypass. * Body mass index (BMI) between 16.5 and 31 kg/m². * American Society of Anesthesiologists (ASA) physical status classification of II or III.

Exclusion criteria

* Refusal to participate, refusal to sign the informed consent form, or inability to communicate. * Participation in other clinical trials concurrently. * Combined coronary artery bypass grafting or ascending aorta surgery. * Emergency surgery. * Active infective endocarditis. * Previous history of cardiac surgery. * Preoperative presence of neurocognitive disorders (NCD), depression, or other psychiatric conditions. * Known abuse of alcohol, drugs, or anesthetics. * Pregnant or breastfeeding women. * Presence of other serious comorbidities that may impede enrollment or affect survival, such as malignancies or severe disabilities. Termination of Intervention Intervention will be terminated for the following reasons: * Withdrawal of consent and request to exit the trial during the study period. * Significant changes in surgical approach: including the addition of deep hypothermic circulatory arrest, intra-aortic balloon counterpulsation (IABP) support, extracorporeal membrane oxygenation (ECMO) support, etc. * Medical necessity for termination of intervention, as determined by the investigator, for example: use of cardiopulmonary bypass more than twice during surgery; unexpected difficulties in weaning from cardiopulmonary bypass or extubation; continued treatment may pose a risk to the patient.

Design outcomes

Primary

MeasureTime frame
Length of hospital stayWithin 1 month after surgery

Secondary

MeasureTime frameDescription
Duration of mechanical ventilation after surgeryWithin 1 week after surgery
Postoperative bowel motilitywithin 1 month after surgery
Overall hospitalization costsWithin 3 months after surgery
Transfusion requirementswithin 1 month after surgery
Length of ICU stayWithin 1 month after surgery
Quality of recoverywithin 1 month after surgeryassessed using the 15-item Quality of Recovery-15 (QoR-15) scale, with each item scored from 0 (very poor) to 10 (very good), for a total score of 150
Chronic painwithin 6 months after surgeryDiagnostic Criteria of Chronic (postsurgical) Pain 1. Chronic pain (persistent or recurrent for longer than 3 months) is present. 2. The pain began or increased in intensity after surgery. 3. The pain is in an area of preceding surgery. 4. The pain persisted for at least 3 months after the initiating event. 5. The pain is not better accounted for by an infection, a malignancy, a pre-existing pain condition or any other alternative
Patient's subjective comfortwithin 6 months after surgeryassessed using the Bruggrmann Comfort Scale (BCS),it is a scoring tool for assessing patient comfort, ranging from 0 (persistent pain) to 4 (pain-free even when coughing)
Postoperative complicationswithin 6 months after surgeryIncluding mortality and complications both in-hospital and post-discharge
Postoperative acute painwithin 1 month after surgeryassessed using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain)

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026